|
|
|
|
||
Re: of interestThanks for posting, JV. Bayer agreement entitles IMGN to up to $170.5 million in milestones (of which at least 10 million has already been received) and royalties of 4-7%. Phase II study, designed to support marketing registration, should report in November 2017. Could help with finances. |
return to message board, top of board |